Kaken Pharmaceutical Co., Ltd. announced planned changes to its directors and auditors in late June 2026, with the appointment of a new executive officer effective July 1, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4521","jir_company_name":"Kaken Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4521-20260327-01.pdf","jir_short_summary":"Kaken Pharmaceutical Co., Ltd. announced planned changes to its directors and auditors in late June 2026, with the appointment of a new executive officer effective July 1, 2026.","jir_summary":"### Overview of Executive Changes\nAt the board of directors meeting held on March 27, 2026, Kaken Pharmaceutical Co., Ltd. resolved changes to its directors, auditors, and executive officers. All directors are scheduled for reappointment at the 106th Annual General Meeting of Shareholders to be held in late June 2026, with no change to the representative. Regarding auditors, one new outside auditor will be appointed, one outside auditor will retire, and one full-time auditor will be reappointed. One new executive officer is scheduled to assume office effective July 1, 2026.\n\n### Upcoming Schedule and Organizational Structure\nElection of directors and auditors will be decided at the Annual General Meeting of Shareholders scheduled for June 2026. Under the new structure, President Hiroyuki Horiuchi will lead alongside managing directors, directors, outside directors, auditors, outside auditors, and executive officers fulfilling their respective roles. This will establish a system aimed at ensuring management continuity and strengthening supervisory functions.","jir_financial_highlights":"Director Changes: Late June 2026 (All five current directors and three outside directors are scheduled for reappointment (no change in representative))\nAuditor Changes: Late June 2026 (One new outside auditor to be appointed, one outside auditor to retire, one full-time auditor to be reappointed)\nExecutive Officer Changes: Effective July 1, 2026 (One new executive officer to be appointed)","jir_category":"","jir_hashtags":"#KakenPharmaceutical, #ExecutivePersonnelChanges, #JapaneseStocks","jir_key_figures":"Scheduled Director Change Date: Late June 2026\nScheduled Auditor Change Date: Late June 2026\nScheduled Executive Officer Change Date: Effective July 1, 2026","jir_meta_title":"Kaken Pharmaceutical Announces Director and Auditor Changes in June 2026 and Executive Officer Change in July","jir_meta_description":"Kaken Pharmaceutical Co., Ltd. plans changes to its directors and auditors in June 2026 and announces the appointment of a new executive officer effective July 1, with no change to its representative.","jir_og_title":"Kaken Pharmaceutical Announces 2026 Executive Personnel Changes","jir_og_description":"Kaken Pharmaceutical plans changes to its directors and auditors in June 2026 and the appointment of a new executive officer in July.","jir_og_image_url":"\/assets\/og\/company-executive_change.jpg","jir_chart_data_collection":"[]","ir_related_company":9082,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-37474","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n